41 results
424B3
QTTB
Q32 Bio Inc.
29 Apr 24
Prospectus supplement
5:10pm
anticipated.
The Biologics Price Competition and Innovation Act of 2009, or BPCIA, was enacted as part of the ACA to establish an abbreviated … . For example, on March 10, 2023, Silicon Valley Bank, or SVB, was closed by the California Department of Financial Protection and Innovation, which
8-K
EX-99.2
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
and Innovation Act of 2009, or BPCIA, was enacted as part of the ACA to establish an abbreviated pathway for the approval of biosimilar … problems. For example, on March 10, 2023, Silicon Valley Bank, or SVB, was closed by the California Department of Financial Protection and Innovation
8-K
EX-99.3
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
Innovation Fund and Sanofi Ventures.
Our Strategy
Our mission is to develop therapeutics that restore healthy immune regulation for patients with severe … on trade secrets and know-how relating to our proprietary technology and product candidates, continuing technological innovation, and in-licensing
8-K
EX-99.1
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
, Atlas Venture, Abingworth, Bristol Myers Squibb, Acorn Bioventures, Osage University Partners, CU Healthcare Innovation Fund, Sanofi Ventures, Agent
424B3
n5yl527bq9iz4cf
13 Mar 24
Prospectus supplement
1:36pm
424B3
15e61q4i 6q9
14 Feb 24
Prospectus supplement
4:10pm
S-4/A
t9zc6t r1ajrksdc
29 Jan 24
Registration of securities issued in business combination transactions (amended)
12:00am
S-4
EX-10.48
iw4c4wp
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
S-4
ykyhzgh8kqt7sex0
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
S-4
EX-10.36
dtndvw3ec919a7hy1t
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
S-4
EX-10.43
so7pp25 pw0h88l4lqd
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
425
vlli z2maup
16 Nov 23
Business combination disclosure
7:17am
8-K
EX-99.1
pdsvulfn
16 Nov 23
Q32 Bio and Homology Medicines Announce Merger Agreement
7:16am
8-K
EX-99.1
9hrzfyczrrotpcgcwa
10 Oct 23
Regulation FD Disclosure
5:22pm